Skip to main content
Client Work

DNA Continuity Fund I completed a quasi-equity investment in Groupe Sacs Frontenac

Fasken
Reading Time 1 minute read
Share
  • LinkedIn

Overview

Client

DNA Continuity Fund I, L.P.

DNA Continuity Fund I completed a quasi-equity investment in Groupe Frontenac Inc.

This investment will allow the company to grow its business by increasing its production and expanding its facilities.

Groupe Frontenac Inc. is a privately owned family business operating in the manufacturing of paper packaging products. The company specializes in paper bags, commercial, industrial, e-commerce packaging products, and food packaging products.

The DNA Fund is a clean investment fund of Investissement Québec designed to support the recovery of promising businesses in Quebec that require funding and need to realign their business plan.

A Fasken team composed of Denis Chaurette and Vincent Chaurette advised DNA Continuity Fund I in connection with this investment.

Jurisdiction

  • Québec

Team

  • Denis Chaurette, Partner, Montréal, QC, +1 514 397 5210, dchaurette@fasken.com
  • Vincent Chaurette, Partner, Montréal, QC, +1 514 397 4351, vchaurette@fasken.com